Sheraz Yaqub
@YaqubSheraz
Followers
357
Following
351
Media
20
Statuses
137
HPB surgeon @Oslo University Hospital, Assoc. Professor of Surgery @University of Oslo. Views are my own.
Joined September 2012
PUMP-2 published in JCO! HAIP chemo for intrahepatic cholangiocarcinoma #pump #CCA @FlavioRochaMD @ArndtVogel @curecc @timpawlik @DrAngelaLamarca @LorenzaRimassa @SyedAAhmad5 @JCO_ASCO
https://t.co/vG6tVXEoQ8
ascopubs.org
PURPOSEThe 3-year overall survival (OS) for advanced intrahepatic cholangiocarcinoma (iCCA) confined to the liver after systemic chemotherapy with gemcitabine-cisplatin (gem-cis) is only 3%. Hepatic...
7
33
85
Please help us better understand current management of synchronous CRLM by taking this @EAHPBA endorsed survey by @jengstrand from @HpbKarolinska A special plea to our colorectal surgeon & GI onc colleagues, help us disseminate this in your network 👉 https://t.co/UsfgZuBjrr
0
9
11
NordicHPB ongoing! Great talk on Locally Advanced Pancreatic Cancer from @FlavioRochaMD! Emphasis on staging laparoscopy prior neoadjuvant!
0
4
13
Prof Buchler @ChampalimaudF gives his “Lessons For Young Surgeons” and his “Lessons For The Teachers” at the @EurPancClub #EPC2025. A living legend 👑 in #Pancreas #Surgery
2
40
144
Had an excellent morning lecture from Prof Tom Hemming Karlsen about EASL Lancet Liver Commission, highlighting the importance of primary prevention of liver disease & its implications for public health @EAHPBA @EASLedu @IHPBA @TheLancet @tomhemmingk @Oslounivsykehus @UniOslo
0
2
3
PREPOSTEROUS trials 1 & 2 (liver & pancreas) presented by Tea Kontio at @EAHPBA 2025 Dublin in Clinical Trials Session RCT comparing pre- versus postop start of thromboprophylaxis in HPB surgery Recruitment : 60% for liver, 40% for pancreas New centers still welcome!
1
6
25
BTC care is evolving fast—catch up on the latest insights from @PeerView, @ArndtVogel, @HardingJJMD & @MacarullaTeresa in this on-demand #ASCO25 symposium. 📽️ Watch the recording:
0
13
20
ASAC trial: Daily #Aspirin fails to improve DFS in #CRC liver mets & may pose harm. OS worse in aspirin arm (76.1% vs 84.9%, HR 1.60). “A strong cautionary signal,” says Jason Zell, DO, MPH of @UCIrvineHealth. https://t.co/Tl3gPTjMOw
#ASCO25 #ColorectalCancer @YaqubSheraz
oncologynewscentral.com
Daily adjuvant aspirin had no benefit in patients with colorectal cancer liver metastases, and resulted in more adverse events, new phase 3 data show.
0
2
3
Scandinavian 🇳🇴🇸🇪🇩🇰ASAC trial (RCT) results at #ASCO2025: 466 patients randomized post-surgery for colorectal cancer liver mets; Aspirin did not improve 3y DFS vs placebo. Conclusion: ASA should NOT be used in this setting. @Oslounivsykehus @forskningsradet @IHPBA @EAHPBA @ASCO
1
6
25
Original Article: Encorafenib, Cetuximab, and mFOLFOX6 in BRAF-Mutated Colorectal Cancer (BREAKWATER phase 3 trial) https://t.co/NNkryRQjCa
#ASCO25 | @ASCO
0
5
6
Excited for the ASCO! Looking forward to sharing breakthroughs,networking with brilliant minds, and forging new research collaborations. Can't wait to connect with old friends and new colleagues! Let’s work together #beatcancer! @UniOslo_MED @IHPBA @EAHPBA @ASCO @Oslounivsykehus
0
1
15
Join us for NordicHPB/NOLCA conference in Helsinki 18.-19. September 2025. Stellar speakers on HPB surgery, advanced endoscopy (ERCP/EUS), robotic surgery and oncology! 10 days left to secure your place for early bird price (before May 19)! See https://t.co/jUqnqzM0mh for info!
0
3
14
Read our early results on liver transplantation for non-resectable intrahepatic cholangiocarcinoma: TESLA trial https://t.co/sNZ8UoWkXp
@BJSurgery @hpb_so @pdline @UniOslo @Oslounivsykehus
academic.oup.com
Intrahepatic cholangiocarcinoma (iCCA) is an aggressive biliary tract cancer with high mortality rate and the incidence is increasing. Surgical resection i
0
8
30
We are looking for a colleague to join us in one of the highest volume liver transplant centres in Europe. Closing date 31.1.25 @uhbtrust @Bham_HPB_LTx @UHB_HPB @IHPBA @_ILTS_ @NHSBT @BTStransplant @SoMeTransplant please retweet 🙏 https://t.co/xVkuDIvTtN
3
27
32
CRS-HIPEC and liver surgery provides long-term survival for selected patients with CRC metastases to the liver and peritoneum. @Oslounivsykehus @hpb_so @AnnalsofSurgery Cytoreductive Surgery With Hyperthermic Intraperitoneal... : Annals of Surgery
journals.lww.com
a poor prognosis. In selected patients, a benefit in overall survival (OS) was shown for both peritoneal metastases (PM-CRC) offered CRS-HIPEC, and CLM treated with surgical resection. However, the...
0
13
42
Congratulations @UmairMajid! Today’s PhD ceremony at @UniOslo on “Macrophage Dynamics in the Human Colon” was excellent. Thanks to Profs Palmquist, Helgeland, Inngjerdingen, and Dean Chaudhry for the great discussion! @Oslounivsykehus @UniOslo_MED @hpb_so
0
0
13
🏔️ A new milestone has been reached! 🔵 Out now in @TheLancet Transmet Trial 💥 Liver Transplantation + chemotherapy superior to chemo alone in permanently unresectable CRLM 📈 5-year overall survival 56·6% vs. 12.6% A new era has begun?! 🧐 https://t.co/aZ41e8jDVK
5
104
296
Great State-of-the-art lecture on Cholangiocarcinoma by @FlavioRochaMD at Nordic HPB meeting 🇳🇴🇸🇪🇩🇰🇫🇮 Thank you for shedding light on this challenging topic. @IHPBA @hpb_so @EAHPBA @xtofero @AAFretland @Oslounivsykehus @UniOslo_MED
0
5
22
Great discussions today with @FlavioRochaMD & @sparrelid visiting HPB dept @Oslounivsykehus. Looking forward to Nordic HPB in Bergen @hpb_so @IHPBA @HpbKarolinska @xtofero @knutjla @RoesokMD @OHSUsurgery
Great to catch up with fellow #HarvardSLP2024 alum @YaqubSheraz at his 🏥 shop in Oslo 🇳🇴 Looking forward to many collaborations in #HPB
0
2
25
Well done @usmsaeed ! Excellent PhD ceremony today at @UniOslo on thesis “BMI and cancer epidemiology” Thanks to the committee for fantastic discussion Profs Amjad Parvaiz @MalinASund @KnutAugestad and Dean Magnus Løberg. @Oslounivsykehus @me4_so @hpb_so
1
1
26